Pliva's Indian R&D centre gets Government welcome
Pliva's venture into the Indian subcontinent received a boost as it was revealed the Governor of Goa would inaugurate the newly built research and development facility of Pliva Research, India.
Archives for June 19, 2006
Vical's avian flu vaccine meets NIH funding criteria
Preclinical data from Vical's avian flu DNA vaccine program has resulted in the company coming one step closer to $2.6m (€2m) in funding for further development of the vaccine under a grant awarded by the US government.
End-to-end pharma logistics now a reality
Newly-formed Sentry Logistic Solutions has built its first bridge, forming a partnership with BioStorage Technologies to offer global biopharma companies the first cold chain storage/logistics service that spans all phases of drug development.
PerkinElmer's third acquisition of 2006 strengthens offering
PerkinElmer has announced the acquisition of C&A Service Solutions that will strengthen its OneSource laboratory service by channelling its range of services into a single outlet.
Strong sales lead Laureate to expand on manufacturing
Laureate Pharma is planning to invest up to $9m (€7.1m) to expand its biopharmaceutical manufacturing facility in New Jersey with a new pilot production plant, as it seeks more capacity to cope with increased demand from clients for protein-based...
Schering-Plough adopts global clinical trials model
Schering-Plough has announced plans to adopt a new global model to standardise its clinical trial operations throughout the world - aimed at improving trial consistencies, efficiencies and saving money.
Quintiles celebrates two industry awards
Top international clinical research organisation (CRO) Quintiles is celebrating after winning two industry awards for its work in the Asia Pacific region.
GlaxoSmithKline extends Cytokinetics cancer collaboration
GlaxosmithKline (GSK) has agreed to continue its collaboration with CytoKinetics, which focused towards the mitotic kinesin, centromere-associated protein E (CENP-E) that has evolved to become a novel and viable drug target.
Sanofi lets Novozymes buy Delta Biotechnology
Danish biotechnology firm Novozymes has acquired Delta Biotechnology from sanofi-aventis, looking to strengthen its bioprocessing expertise in enzymes and microorganisms with Delta's ability to manufacture recombinant proteins from baker's yeast.